These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35820535)

  • 1. Cefiderocol heteroresistance in Klebsiella pneumoniae is linked to mutations in the siderophore receptor cirA and β-lactamase activities.
    Moon SH; Udaondo Z; Jun SR; Huang E
    Int J Antimicrob Agents; 2022 Sep; 60(3):106635. PubMed ID: 35820535
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterisation of cefiderocol-resistant spontaneous mutant variants of Klebsiella pneumoniae-producing NDM-5 with a single mutation in cirA.
    Mezcord V; Traglia GM; Pasteran F; Escalante J; Lopez C; Wong O; Rojas L; Marshall SH; Tolmasky ME; Bonomo RA; Ramirez MS
    Int J Antimicrob Agents; 2024 May; 63(5):107131. PubMed ID: 38432605
    [No Abstract]   [Full Text] [Related]  

  • 3.
    McElheny CL; Fowler EL; Iovleva A; Shields RK; Doi Y
    Microbiol Spectr; 2021 Dec; 9(3):e0177921. PubMed ID: 34756080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of High-Level Cefiderocol Resistance in Carbapenem-Resistant Klebsiella pneumoniae from Bloodstream Infections in Patients with Hematologic Malignancies in China.
    Lan P; Lu Y; Chen Z; Wu X; Hua X; Jiang Y; Zhou J; Yu Y
    Microbiol Spectr; 2022 Apr; 10(2):e0008422. PubMed ID: 35323031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.
    Witt LS; Steed DB; Burd EM; Ozturk T; Davis MH; Satola SW; Weiss DS; Jacob JT
    J Antimicrob Chemother; 2022 Aug; 77(9):2569-2571. PubMed ID: 35726616
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.
    Longshaw CM; Santerre Henriksen A; Slover C; Yamano Y; Karas JA
    J Antimicrob Chemother; 2022 Sep; 77(10):2895-2896. PubMed ID: 35971761
    [No Abstract]   [Full Text] [Related]  

  • 7. Catecholate siderophore receptor CirA impacts cefiderocol susceptibility in Klebsiella pneumoniae.
    Lan P; Lu Y; Jiang Y; Wu X; Yu Y; Zhou J
    Int J Antimicrob Agents; 2022 Oct; 60(4):106646. PubMed ID: 35918032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evolution to high-level cefiderocol resistance of NDM-1-producing Klebsiella pneumoniae, followed by intra-hospital cross-transmission.
    Tascini C; Coppi M; Antonelli A; Niccolai C; Bartolini A; Pecori D; Sartor A; Giani T; Rossolini GM
    Clin Microbiol Infect; 2024 Mar; 30(3):398-400. PubMed ID: 37979689
    [No Abstract]   [Full Text] [Related]  

  • 9. High-level expression of chromosomally encoded SHV-1 β-lactamase reduces the susceptibility to cefiderocol of clinical isolates of Klebsiella pneumoniae.
    Charfi R; Tazi A; Sereme Y; Plainvert C; Poupet H; Doloy A; Guyonnet C; Morand P; Loubinoux J; Poyart C; Mammeri H
    J Antimicrob Chemother; 2024 Jul; 79(7):1711-1714. PubMed ID: 38785356
    [No Abstract]   [Full Text] [Related]  

  • 10. Cefiderocol Resistance in Klebsiella pneumoniae Is Linked to SHV Extended-Spectrum β-Lactamase Activities and Functional Loss of the Outer Membrane Porin OmpK35.
    Moon SH; Huang E
    Microbiol Spectr; 2023 Jun; 11(3):e0349622. PubMed ID: 37097174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Development of Cefiderocol Resistance in Carbapenem-resistant Enterobacter cloacae During Therapy Is Associated With Heterogeneous Mutations in the Catecholate Siderophore Receptor cirA.
    Klein S; Boutin S; Kocer K; Fiedler MO; Störzinger D; Weigand MA; Tan B; Richter D; Rupp C; Mieth M; Mehrabi A; Hackert T; Zimmermann S; Heeg K; Nurjadi D
    Clin Infect Dis; 2022 Mar; 74(5):905-908. PubMed ID: 34079986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia.
    Song W; Moland ES; Hanson ND; Lewis JS; Jorgensen JH; Thomson KS
    J Clin Microbiol; 2005 Sep; 43(9):4891-4. PubMed ID: 16145169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of cefiderocol in combination with new β-lactam/β-lactamase inhibitor combinations (βL-βLICs) against multidrug resistant KPC-producing Klebsiella pneumoniae.
    Gaibani P; Lazzarotto T; Viale P; Ambretti S
    J Antibiot (Tokyo); 2023 Nov; 76(11):682-688. PubMed ID: 37648744
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete Genome Sequence of a Multidrug-Resistant
    Gaibani P; Amadesi S; Lazzarotto T; Ambretti S
    Microb Drug Resist; 2022 Sep; 28(9):916-920. PubMed ID: 36112395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
    Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
    Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data?
    Shields RK
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bloodstream infection by two subpopulations of Klebsiella pneumoniae ST1685 carrying KPC-33 or KPC-14 following ceftazidime/avibactam treatment: considerations regarding acquired heteroresistance and choice of carbapenemase detection assay.
    Bianco G; Boattini M; Iannaccone M; Cavallo R; Costa C
    J Antimicrob Chemother; 2020 Oct; 75(10):3075-3076. PubMed ID: 32676660
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid selection of a cefiderocol-resistant Escherichia coli producing NDM-5 associated with a single amino acid substitution in the CirA siderophore receptor.
    Jousset AB; Poignon C; Yilmaz S; Bleibtreu A; Emeraud C; Girlich D; Naas T; Robert J; Bonnin RA; Dortet L
    J Antimicrob Chemother; 2023 Apr; 78(4):1125-1127. PubMed ID: 36864015
    [No Abstract]   [Full Text] [Related]  

  • 20. New Delhi Metallo-Beta-Lactamase Facilitates the Emergence of Cefiderocol Resistance in Enterobacter cloacae.
    Nurjadi D; Kocer K; Chanthalangsy Q; Klein S; Heeg K; Boutin S
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0201121. PubMed ID: 34871093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.